We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The public continues to lose trust in the pharma industry, viewing it far differently than the industry perceives itself, according to a new PricewaterhouseCoopers report.
Medtronic’s Physio-Control business has suspended U.S. shipments of external defibrillators and other products from its Redmond, Wash., facility in a move that could allow rival devicemakers to gain market share.
Eli Lilly announced it is stopping construction of an insulin manufacturing plant in Prince William County, Va., because demand is not as high as the company thought when it planned the facility in 2003.
The public continues to lose trust in the pharma industry, viewing it far differently than the industry perceives itself, according to a new PricewaterhouseCoopers report.
VaxGen announced that it will cut 51 percent of its work force as part of restructuring efforts, following the federal government’s unilateral cancellation of what would have been an $877.5 million contract to develop a next-generation anthrax vaccine (DID, Dec. 21, 2006).
Sanofi pasteur has completed production of more than 170 million doses of influenza vaccine, making it the largest contributor to this year’s global supply, the company said.
A proposal to discuss conflicts of interest between drug companies and physicians at the American Society of Hypertension’s (ASH) upcoming annual meeting in Chicago in May has caused a public controversy.